2-piperidone has been researched along with Endotoxemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, CH; Cho, YM; Kim, EK; Min, SH; Oh, TJ | 1 |
Choi, Y; Han, G; Han, JW; Han, SB; Kang, JS; Kim, HM; Park, SK; Yang, JS; Yoon, YD | 1 |
1 trial(s) available for 2-piperidone and Endotoxemia
Article | Year |
---|---|
Effects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, on lipid metabolism and endotoxemia after a high-fat meal in patients with type 2 diabetes.
Topics: Adiponectin; Adult; Aged; Apolipoprotein B-100; Apolipoprotein B-48; Blood Glucose; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Cytokines; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endotoxemia; Endotoxins; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Middle Aged; Piperidones; Postprandial Period; Pyrimidines; RNA, Messenger; Subcutaneous Fat, Abdominal; Transcriptome; Triglycerides; Tumor Necrosis Factor-alpha | 2017 |
1 other study(ies) available for 2-piperidone and Endotoxemia
Article | Year |
---|---|
Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model.
Topics: Animals; Blotting, Western; Cell Line; Cell Survival; Cytokines; Electrophoretic Mobility Shift Assay; Endotoxemia; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Hydroxamic Acids; Interleukin-1beta; Interleukin-6; Macrophages; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Molecular Structure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Piperidones; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2008 |